Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IMIQUIMOD for Kaposi's sarcoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 15 adverse event reports in the FDA FAERS database where IMIQUIMOD was used for Kaposi's sarcoma.

Most Reported Side Effects for IMIQUIMOD

Side Effect Reports % Deaths Hosp.
Off label use 264 15.6% 4 15
Product use in unapproved indication 179 10.6% 0 4
Erythema 171 10.1% 1 14
Drug ineffective 123 7.3% 2 9
Fatigue 118 7.0% 3 12
Influenza like illness 101 6.0% 0 13
Pain 98 5.8% 0 3
Application site erythema 95 5.6% 0 3
Nausea 90 5.3% 4 15
Headache 79 4.7% 3 11
Scab 73 4.3% 1 6
Pruritus 72 4.3% 1 4
Application site pain 68 4.0% 1 4
Pyrexia 62 3.7% 1 10
Chills 56 3.3% 1 12

Other Indications for IMIQUIMOD

Actinic keratosis (331) Basal cell carcinoma (276) Product used for unknown indication (170) Anogenital warts (86) Skin papilloma (74) Skin cancer (57) Precancerous skin lesion (48) Squamous cell carcinoma of skin (45) Squamous cell carcinoma (39) Molluscum contagiosum (36)

Other Drugs Used for Kaposi's sarcoma

POMALIDOMIDE (268) DOXORUBICIN (238) PACLITAXEL (122) VINCRISTINE (78) BLEOMYCIN (58) LENALIDOMIDE (54) ETOPOSIDE (38) RITUXIMAB (27) PREDNISONE (23) GEMCITABINE (21)

Related Pages

IMIQUIMOD Full Profile All Kaposi's sarcoma Drugs IMIQUIMOD Demographics IMIQUIMOD Timeline